Tuberculosis

Tuberculosis of the central nervous system: Recognition, diagnosis and treatment in a low-prevalence country

Tuberculosis (TB) is one of the greatest threats to global public health, with 9.2 million new cases in 20061 and has become increasingly common in the UK. Central nervous system (CNS) infection with Mycobacterium tuberculosis (MTB) is relatively rare but is associated with a serious risk of neurological morbidity or death. Delays in diagnosis worsen prognosis and even with anti-tuberculous therapy up to 30% of tuberculous meningitis (TBM) patients may die.2 TBM and tuberculomas can mimic other CNS pathologies. Careful analysis of the clinical features, CSF examination and pragmatic use of diagnostic tests can aid the diagnosis. Prolonged anti-tuberculous treatment is required and presumptive treatment should not be delayed for microbiological confirmation of the disease.

Please subscribe to see more.
Subscribe
Already a member? Log in here

Tuberculosis of the central nervous system: Recognition, diagnosis and treatment in a low-prevalence country Read More

Tuberulous Meningitis masked by Temazepam Overdose

A 47 year old Chinese businessman was found unconscious at home following an overdose of 280 mg temazepam. He was found by his sister who had visited because he had not returned her telephone calls for several weeks. He had been resident in England for 8 years but returned to Hong Kong frequently. Since his last visit to Hong Kong, 4 months previously, his mood had been low and he had developed anorexia, weight loss and insomnia. Physical examination and routine investigations were unremarkable and a diagnosis of depression was made. Citalopram 10 mg daily and temazepam 10 mg daily had been prescribed one day prior to admission.

Please subscribe to see more.
Subscribe
Already a member? Log in here

Tuberulous Meningitis masked by Temazepam Overdose Read More

Management of Tuberculosis for the Acute Physician

Abstract

Tuberculosis is increasing world-wide and also in England and Wales, where there are marked geographical and ethnic variations. Acute physicians should be aware of this, and also of the variable manifestations of this multisystem disease, as well as current epidemiology which informs clinical risk stratification. Treatment is highly evidence based, and bacteriological confirmation should be sought whenever possible, partly because of the current level of drug resistance.

Please subscribe to see more.
Subscribe
Already a member? Log in here

Management of Tuberculosis for the Acute Physician Read More

Shopping Basket
Scroll to Top